{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:14:01Z","timestamp":1791274441056,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.bone.2012.11.045","type":"journal-article","created":{"date-parts":[[2012,12,9]],"date-time":"2012-12-09T09:46:29Z","timestamp":1355046389000},"page":"160-166","source":"Crossref","is-referenced-by-count":53,"title":["Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1\u201331)NH2] in postmenopausal women with osteoporosis"],"prefix":"10.1016","volume":"53","author":[{"given":"K.","family":"Henriksen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.R.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.J.","family":"Riis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Tavakkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Alexandersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Byrjalsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Valter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.S.","family":"Nedergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.S.","family":"Teglbj\u00e6rg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sturmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mitta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"Nino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.A.","family":"Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.A.","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2012.11.045_bb0005","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","article-title":"Bone quality\u2014the material and structural basis of bone strength and fragility","volume":"354","author":"Seeman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2012.11.045_bb0010","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(02)08827-X","article-title":"Treatment of postmenopausal osteoporosis","volume":"359","author":"Delmas","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2012.11.045_bb0015","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1517\/14712598.2010.506870","article-title":"PTH analogues and osteoporotic fractures","volume":"10","author":"Verhaar","year":"2010","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/j.bone.2012.11.045_bb0020","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1517\/14656566.5.5.1153","article-title":"A review of teriparatide and its clinical efficacy in the treatment of osteoporosis","volume":"5","author":"Dobnig","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.bone.2012.11.045_bb0025","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/jbmr.5650090620","article-title":"Further definition of the protein kinase C activation domain of the parathyroid hormone","volume":"9","author":"Jouishomme","year":"1994","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.11.045_bb0030","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/jbmr.5650090807","article-title":"Parathyroid hormone fragments may stimulate bone growth in ovariectomized rats by activating adenylyl cyclase","volume":"9","author":"Rixon","year":"1994","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.11.045_bb0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF02529728","article-title":"Stimulation of the growth of femoral trabecular bone in ovariectomized rats by the novel parathyroid hormone fragment, hPTH-(1\u201331)NH2 (Ostabolin)","volume":"58","author":"Whitfield","year":"1996","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2012.11.045_bb0040","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S8756-3282(00)00355-0","article-title":"Comparison of bone formation responses to parathyroid hormone(1\u201334), (1\u201331), and (2\u201334) in mice","volume":"27","author":"Mohan","year":"2000","journal-title":"Bone"},{"key":"10.1016\/j.bone.2012.11.045_bb0045","first-page":"2739","article-title":"Comparison of the biochemical responses to human parathyroid hormone-(1\u201331)NH2 and hPTH-(1\u201334) in healthy humans","volume":"84","author":"Fraher","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2012.11.045_bb0050","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1177\/0091270010372625","article-title":"Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials","volume":"51","author":"Karsdal","year":"2011","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.bone.2012.11.045_bb0055","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1463-1326.2009.01150.x","article-title":"Oral insulin \u2014 a review of current status","volume":"12","author":"Iyer","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.bone.2012.11.045_bb0060","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/clpt.2009.159","article-title":"Orally administered glucagon-like peptide-1 affects glucose homeostasis following an oral glucose tolerance test in healthy male subjects","volume":"86","author":"Steinert","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2012.11.045_bb0065","first-page":"S370","article-title":"Nighttime dosing with an oral calcitonin tablet significantly reduces plasma CTX-1","volume":"24","author":"Mehta","year":"2009","journal-title":"J Bone Miner Res"},{"issue":"Suppl. 1","key":"10.1016\/j.bone.2012.11.045_bb0070","first-page":"1249","article-title":"Pharmacokinetic clinical studies of an orally delivered recombinant PTH analog","volume":"24","author":"Mehta","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.11.045_bb0075","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1210\/jc.2003-030768","article-title":"Efficacy and safety of human parathyroid hormone-(1\u201384) in increasing bone mineral density in postmenopausal osteoporosis","volume":"88","author":"Hodsman","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.bone.2012.11.045_bb0080","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.bone.2012.01.009","article-title":"The single dose pharmacokinetic profile of a novel oral human parathyroid hormone formulation in healthy postmenopausal women","volume":"50","author":"Hammerle","year":"2012","journal-title":"Bone"},{"issue":"8","key":"10.1016\/j.bone.2012.11.045_bb0085","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/jbmr.1602","article-title":"A phase 3 trial of the efficacy and safety of oral recombinant calcitonin: the ORACAL trial","volume":"27","author":"Binkley","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.11.045_bb0090","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2012.11.045_bb0095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1359\/jbmr.2003.18.1.18","article-title":"The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis","volume":"18","author":"Marcus","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.11.045_bb0100","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00198-010-1376-1","article-title":"Variability in the measured response of bone to teriparatide","volume":"22","author":"Heaney","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2012.11.045_bb0105","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00198-007-0336-x","article-title":"Hetereogeneity in skeletal response to full-length parathyroid hormone in the treatment of osteoporosis","volume":"18","author":"Sellmeyer","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2012.11.045_bb0110","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1359\/jbmr.081256","article-title":"Vertebral fracture risk is reduced in women who lose femoral neck BMD with teriparatide treatment","volume":"24","author":"Watts","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2012.11.045_bb0115","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1359\/jbmr.2001.16.3.441","article-title":"Stimulation of protein kinase C activity in cells expressing human parathyroid hormone receptors by C- and N-terminally truncated fragments of parathyroid hormone 1\u201334","volume":"16","author":"Whitfield","year":"2001","journal-title":"J Bone Miner Res"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328212014081?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328212014081?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,20]],"date-time":"2018-10-20T09:31:26Z","timestamp":1540027886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328212014081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S8756328212014081"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2012.11.045","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}